Skip to main content
Julia Fehniger, MD, Obstetrics & Gynecology, Portland, OR

Julia Fehniger MD FACOG (She/Her)

Gynecologic Oncology


Gynecologic Oncologist, Legacy Health

Join to View Full Profile
  • 1130 NW 22nd AveSte 110Portland, OR 97210

  • Phone+1 503-413-8654

Dr. Fehniger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineFellowship, Gynecologic Oncology, 2017 - 2020
  • University of Chicago
    University of ChicagoResidency, Obstetrics and Gynecology, 2013 - 2017
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 2013

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 2021 - 2026
  • OR State Medical License
    OR State Medical License 2021 - 2025
  • NY State Medical License
    NY State Medical License 2017 - 2022
  • IL State Medical License
    IL State Medical License 2013 - 2017
  • Obstetrics & Gynecology
    American Board of Obstetrics and Gynecology Obstetrics & Gynecology
  • Gynecologic Oncology
    American Board of Obstetrics and Gynecology Gynecologic Oncology

Publications & Presentations

PubMed

Lectures

  • Genomic mutation profiles of paired ovarian cancers (OC) across time. 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Press Mentions

  • Most Women Treated in New York City for Gynecologic Cancers Are Not at Increased Risk of Death from COVID-19
    Most Women Treated in New York City for Gynecologic Cancers Are Not at Increased Risk of Death from COVID-19July 30th, 2020
  • Dr. Fehniger on Expanding PARP Inhibitors to Other Gynecologic Cancers
    Dr. Fehniger on Expanding PARP Inhibitors to Other Gynecologic CancersFebruary 9th, 2020
  • PARP Inhibitors May Have Benefit in BRCA-Mutant Endometrial Cancers
    PARP Inhibitors May Have Benefit in BRCA-Mutant Endometrial CancersFebruary 8th, 2020

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: